Index of medicine substances

Remifentanil  •  Nervous system | Anesthetics | Anesthetics, general | Opioid anesthetics (N01AH06)

Remimazolam  •  Nervous system | Hypnotics and sedatives | Benzodiazepine derivatives (N05CD14)

Repaglinide  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins (A10BX02)

Respiratory syncytial virus vaccine  •  Antiinfectives for systemic use | Viral vaccines | Other viral vaccines (J07BX05)

Retapamulin  •  Dermatologicals | Antibiotics for topical use | Other antibiotics for topical use (D06AX13)

Reteplase  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Enzymes (B01AD07)

Retifanlimab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors (L01FF10)

Retigabine  •  Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics (N03AX21)

Retinol  •  Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin A, plain (A11CA01)

Retinol + ergocalciferol  •  Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin A and D in combination (A11CBN1)

Retinol + ergocalciferol + fish oil  •  Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin A and D in combination (A11CBN2)

Retinol + ergocalciferol + tocopherol + phytomenadione  •  Blood and blood forming organs | I.v. solution additives | Vitamins (B05XC01)

Retinol + tocopherol  •  Alimentary tract and metabolism | Other vitamin products, combinations | Combinations of vitamins (A11JAN1)

Reviparin  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Heparin group (B01AB08)

Ribavirin  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections (J05AP01)

Ribavirin + interferon alfa 2B  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors (J05AB54)

Ribociclib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Cyclin-dependent kinase (CDK) inhibitors (L01EF01)

Riboflavin  •  Alimentary tract and metabolism | Other plain vitamin preparations (A11HA04)

Rifabutin  •  Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics (J04AB04)

Rifampicin  •  Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics (J04AB02)

Rifampicin + clofazimine + dapsone  •  Antiinfectives for systemic use | Drugs for treatment of lepra (J04BA51)

Rifampicin + isoniazid  •  Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Combinations of drugs for treatment of tuberculosis (J04AM02)

Rifamycin  •  Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics (J04AB03)

Rifaximin  •  Alimentary tract and metabolism | Intestinal antiinfectives | Antibiotics (A07AA11)

Rilmenidine  •  Cardiovascular system | Antiadrenergic agents, centrally acting | Imidazoline receptor agonists (C02AC06)

Rilpivirine  •  Antiinfectives for systemic use | Direct acting antivirals | Non-nucleoside reverse transcriptase inhibitors (J05AG05)

Riluzole  •  Nervous system | Other nervous system drugs | Other nervous system drugs (N07XX02)

Rilzabrutinib  •  ()

Rimantadine  •  Antiinfectives for systemic use | Direct acting antivirals | Cyclic amines (J05AC02)

Rimegepant  •  Nervous system | Antimigraine preparations | Calcitonin gene-related peptide (CGRP) antagonists (N02CD06)